About

Translational Research (TR), a division of Shin Nippon Biomedical Laboratories, Ltd. (SNBL), has developed proprietary technology for nasal drug delivery, "SMART (Simple MucoAdhesive Release Technology)”. SMART is comprised of two technological elements, powder carrier technology and delivery device technology. In addition to licensing out platform technology and products developed in-house to pharmaceutical companies, SNBL provides support for R&D of drug products applying the group’ s vast experience and capacity for drug development as a contract research organization (CRO) and its state-of-the-art preclinical and clinical study facilities recognized world-wide.